Indaptus enters $20M standby equity line with Yorkville; issues 305,960 commitment shares

Indaptus Therapeutics, Inc.

Up to $20M equity purchase agreement with YA II PN (Yorkville) over 36 months.
Shares sold at 97% of lowest 3-day VWAP; 305,960 commitment shares and $25k fee issued.
Exchange cap 2,823,244 shares (19.99% of outstanding) unless price ≥$0.81722 or shareholder approval.
Terminates prior Lincoln Park Capital purchase agreement from December 2022.
Registration statement required before any advances can be drawn.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.